U Hurtenbach
- Immunology top 10%
- Molecular Biology
- Cancer Research
- Hematology top 10%
- Oncology
- Co-authors
- G M ShearerErnst GleichmannGünter J. HämmerlingHubertine HeremansBénédicte DuboisGhislain OpdenakkerStefan MasureRaf Sciot
- Topics
- Immunotherapy and Immune Responses (10 papers)Immune Cell Function and Interaction (9 papers)T-cell and B-cell Immunology (6 papers)
- Cited by
- ImmunologyHematologyCancer Research
- Journals
- Journal of Clinical InvestigationThe Journal of Experimental MedicineThe Journal of Immunology
- Partner nations
- United StatesGermanyJapan
In The Last Decade
U Hurtenbach
29 papers receiving 738 citations
Peers
Comparison fields: 5 of 93
- Immunology 358
- Molecular Biology 161
- Cancer Research 146
- Hematology 125
- Oncology 106
Countries citing papers authored by U Hurtenbach
This map shows the geographic impact of U Hurtenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U Hurtenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U Hurtenbach more than expected).
Fields of papers citing papers by U Hurtenbach
This network shows the impact of papers produced by U Hurtenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U Hurtenbach. The network helps show where U Hurtenbach may publish in the future.
Co-authorship network of co-authors of U Hurtenbach
This figure shows the co-authorship network connecting the top 25 collaborators of U Hurtenbach. A scholar is included among the top collaborators of U Hurtenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U Hurtenbach. U Hurtenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 228 | |
| 2 | 8 | |
| 3 | 28 | |
| 4 | 48 | |
| 5 | 14 | |
| 6 | New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation. | 5 |
| 7 | 16 | |
| 8 | 38 | |
| 9 | 6 | |
| 10 | 22 | |
| 11 | 29 | |
| 12 | 11 | |
| 13 | 7 | |
| 14 | 44 | |
| 15 | 75 | |
| 16 | 22 | |
| 17 | 6 | |
| 18 | 8 | |
| 19 | 1 | |
| 20 | 26 |
About U Hurtenbach
U Hurtenbach is a scholar working on Immunology, Parasitology and Pharmacy, having authored 29 papers that have together received 774 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Immunology (358 citations), Hematology (125 citations) and Cancer Research (146 citations). U Hurtenbach has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include G M Shearer, Ernst Gleichmann, Günter J. Hämmerling, Hubertine Heremans, Bénédicte Dubois, Ghislain Opdenakker, Stefan Masure, Raf Sciot, Liesbet Paemen and Joost van den Oord. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.